Related Experiment Videos
Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse
K M Shannon1, M M Le Beau, D A Largaespada
1Department of Pediatrics, University of California-San Francisco, 513 Parnassus Ave., San Francisco, CA 94143, USA. kevins@itsa.ucsf.edu
Abstract:
Introducing dominant oncogenic alterations uncovered in human myeloid malignancies into the mouse germline provides a powerful approach for studying leukemogenesis. However, little is known about how gene inactivation contributes to the development of myeloid malignancies. We describe how Nf1 mutant mice provide one example in which disrupting a tumor suppressor gene has been used to generate an informative murine leukemia model. We also discuss how chromosome engineering technologies are being harnessed to model the segmental deletions found in myeloid malignancies, and how these approaches can be combined with retrovirally medicated insertional mutagenesis to generate new models and for gene discovery.
Insights
Disrupting tumor suppressor genes like Nf1 in mice creates informative models for studying myeloid leukemia. Combining gene inactivation with chromosome engineering and insertional mutagenesis aids in discovering new genes involved in cancer development.
Area of Science:
- * Oncology
- * Genetics
- * Molecular Biology
Background:
- * Understanding the genetic basis of myeloid malignancies is crucial for developing effective treatments.
- * While oncogenic alterations are well-studied, the role of gene inactivation in myeloid cancer development remains less understood.
- * Murine models are essential for studying complex diseases like leukemogenesis.
Purpose of the Study:
- * To explore how gene inactivation contributes to the development of myeloid malignancies.
- * To highlight the utility of the Nf1 mutant mouse model in studying leukemogenesis.
- * To discuss advanced techniques for modeling myeloid malignancies and discovering novel genes.
Main Methods:
- * Generation of murine leukemia models by introducing dominant oncogenic alterations into the mouse germline.
- * Utilizing Nf1 mutant mice to study the impact of tumor suppressor gene disruption.
- * Employing chromosome engineering to model segmental deletions characteristic of myeloid malignancies.
- * Combining these approaches with retrovirally mediated insertional mutagenesis for gene discovery.
Main Results:
- * Nf1 mutant mice serve as an informative model for studying leukemogenesis.
- * Chromosome engineering effectively models segmental deletions found in myeloid malignancies.
- * The combination of genetic engineering and insertional mutagenesis facilitates the generation of novel disease models.
Conclusions:
- * Targeted gene inactivation, exemplified by Nf1 disruption, is a viable strategy for creating robust murine models of myeloid leukemia.
- * Advanced techniques like chromosome engineering and insertional mutagenesis offer powerful tools for modeling complex genetic alterations and discovering new oncogenes or tumor suppressors in myeloid malignancies.